<html>
<head>
	<title>ctdh20180205_8k.htm</title>

	<!-- Created by RDG HTML Converter v1.1.0.0 2/5/2018 2:54:04 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no"/>
</head>
<body style="font-family: Times\ New\ Roman, Times, serif; font-size: 10pt; margin-left: 10px; margin-right: 10px; cursor: auto;">
<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>UNITED STATES<br>
<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>Washington, D.C. 20549</b></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</p>

<p style="font-family: Times\ New\ Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><br>
<b><font style="font-family:Times New Roman, Times, serif;font-size:10pt;">FORM 8-K</font></b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>CURRENT REPORT<br>
<br>
<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">Pursuant to Section 13 or 15(d) of the<br>
Securities Exchange Act of 1934</font></b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">Date of Report (Date of earliest event reported) <font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><u>&nbsp;&nbsp;&nbsp; <b>February 6, 2018</b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </u></font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><br>
<u><b><font style="font-family:Times New Roman, Times, serif;font-size:10pt;">CTD HOLDINGS, INC.</font></b></u></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Exact name of registrant as specified in charter)</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times\ New\ Roman, Times, serif; width: 100%;">

		<tr>
			<td style="width: 40%; text-align: center; border-bottom: thin solid rgb(0, 0, 0);"><b><font style="font-family:Times New Roman, Times, serif;font-size:10pt;">Florida</font></b></td>
			<td style="width: 4%;">&nbsp;</td>
			<td style="width: 26%; text-align: center; border-bottom: thin solid rgb(0, 0, 0);"><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b>000-25466</b></font></td>
			<td style="width: 4%;">&nbsp;</td>
			<td style="width: 26%; text-align: center; border-bottom: thin solid rgb(0, 0, 0);"><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b>59-3029743</b></font></td>
		</tr>
		<tr>
			<td style="text-align: center; width: 40%;">(State or other Jurisdiction of Incorporation or Organization)</td>
			<td style="width: 4%;">&nbsp;</td>
			<td style="text-align: center; width: 26%;"><font style="font-family:Times New Roman, Times, serif;font-size:10pt;">(Commission File Number)</font></td>
			<td style="width: 4%;">&nbsp;</td>
			<td style="text-align: center; width: 26%;"><font style="font-family:Times New Roman, Times, serif;font-size:10pt;">(IRS Employer Identification No.)</font></td>
		</tr>

</table>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></b><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b></font></p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: Times\ New\ Roman, Times, serif; width: 95%; margin-right: 2.5%; margin-left: 2.5%;">

		<tr>
			<td style="width: 76%; text-align: center; border-bottom: thin solid rgb(0, 0, 0);"><b>6714 NW 16th Street, Suite B, Gainesville</b><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b>, Florida</b></font></td>
			<td style="width: 24%; text-align: center; border-bottom: thin solid rgb(0, 0, 0);"><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b>32563</b></font></td>
		</tr>
		<tr>
			<td style="text-align: center; width: 76%;">(Address of Principal Executive Offices)</td>
			<td style="text-align: center; width: 24%;"><font style="font-family:Times New Roman, Times, serif;font-size:10pt;">(zip code)</font></td>
		</tr>

</table>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><u><b>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; <font style="font-family:Times New Roman, Times, serif;font-size:10pt;">386-418-8060&nbsp;&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp; </font></b></u></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Registrant<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&rsquo;s telephone<br>
number, including area code)</font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#9744;<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp; Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#9744;<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp; Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))</font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#9744;<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&#9744;<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font><br>
<br>
<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &sect;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &sect;240.12b-2).<br>
Emerging growth company&nbsp;</font><font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&#9744;</font><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b>&nbsp;</b></font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.<font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp;</font><font style="font-family:Times New Roman, Times, serif;font-size:10pt;">&#9744;</font><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b>&nbsp;</b></font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Item </b><font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><b> </b><b>8</b><b>.01. </b><b>Other Events</b></font></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">CTD Holdings, Inc. <font style="font-family:Times New Roman, Times, serif;font-size:10pt;">has obtained preliminary data suggesting that Trappsol&reg; Cyclo<sup>TM</sup>, its proprietary formulation of hydroxypropyl beta cyclodextrin, crosses the blood-brain-barrier in individuals suffering from Niemann-Pick disease type C. Data were derived from initial subjects participating in CTD&#39;s phase I clinical trial in the United States (&ldquo;A Phase I Study to Evaluate the Single- and Multiple-dose Pharmacokinetics of Intravenous Trappsol Cyclo (HPBCD) in Patients with Niemann-Pick Disease Type C (NPC-1) and the Effects of Dosing Upon Biomarkers of NPC Disease,&quot; NCT02939547), and phase I/II clinical trial in Europe and Israel (&quot;A Phase I/II Study to Evaluate the Safety and PK of IV Trappsol&reg; Cyclo<sup>TM</sup> (HPBCD) in Patients with Niemann-Pick Disease Type C and Pharmacodynamic Effects of Treatment Upon Markers of Cholesterol Metabolism and Clinical Outcomes,&quot; NCT02912793). Following intravenous administration of Trappsol&reg; Cyclo<sup>TM</sup><sup> </sup>to study subjects, it was detected in subjects&#39; cerebrospinal fluid. The clinical significance of these findings will be determined as part of the final analysis of both clinical trials.</font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</p>

<div id="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div id="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div id="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><b>SIGNATURES</b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:61.5%;margin-right:0pt;margin-top:0pt;text-align:left;"><b>CTD Holdings, Inc.</b></p>

<p style="font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:61.5%;margin-right:0pt;margin-top:0pt;text-align:left;">Date: <font style="font-family:Times New Roman, Times, serif;font-size:10pt;">February 6, 2018</font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:61.5%;margin-right:0pt;margin-top:0pt;text-align:left;">&nbsp;</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:61.5%;margin-right:0pt;margin-top:0pt;text-align:left;">By: <font style="font-family:Times New Roman, Times, serif;font-size:10pt;"><u>/s/ </u><u>Jeffrey L. Tate&nbsp;&nbsp;&nbsp; </u></font></p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:61.5%;margin-right:0pt;margin-top:0pt;text-align:left;">Jeffrey L. Tate</p>

<p style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:61.5%;margin-right:0pt;margin-top:0pt;text-align:left;">Chief <font style="font-family:Times New Roman, Times, serif;font-size:10pt;">Operating Officer</font></p>
</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "ctdh20180205_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 14328}]
{"company-data": {"conformed-name": "CTD HOLDINGS INC", "cik": "0000922247", "assigned-sic": "2860", "irs-number": "593029743", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-25466", "film-number": "18576240"}, "business-address": {"street1": "14120 NW 126TH TERRACE", "city": "ALACHUA", "state": "FL", "zip": "32615-4816", "phone": "386-418-8060"}, "mail-address": {"street1": "14120 NW 126TH TERRACE", "city": "ALACHUA", "state": "FL", "zip": "32615-4816"}, "former-company": {"former-conformed-name": "CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC", "date-changed": "19941012"}}
ctdh20180205_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
February 6, 2018
CTD HOLDINGS, INC.
(Exact name of registrant as specified in charter)
Florida
000-25466
59-3029743
(State or other Jurisdiction of Incorporation or Organization)
(Commission File Number)
(IRS Employer Identification No.)
6714 NW 16th Street, Suite B, Gainesville
, Florida
32563
(Address of Principal Executive Offices)
(zip code)
386-418-8060
(Registrant
's telephone
number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12(b))
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item
8
.01.
Other Events
CTD Holdings, Inc.
has obtained preliminary data suggesting that Trappsol® Cyclo
TM
, its proprietary formulation of hydroxypropyl beta cyclodextrin, crosses the blood-brain-barrier in individuals suffering from Niemann-Pick disease type C. Data were derived from initial subjects participating in CTD's phase I clinical trial in the United States ("A Phase I Study to Evaluate the Single- and Multiple-dose Pharmacokinetics of Intravenous Trappsol Cyclo (HPBCD) in Patients with Niemann-Pick Disease Type C (NPC-1) and the Effects of Dosing Upon Biomarkers of NPC Disease," NCT02939547), and phase I/II clinical trial in Europe and Israel ("A Phase I/II Study to Evaluate the Safety and PK of IV Trappsol® Cyclo
TM
(HPBCD) in Patients with Niemann-Pick Disease Type C and Pharmacodynamic Effects of Treatment Upon Markers of Cholesterol Metabolism and Clinical Outcomes," NCT02912793). Following intravenous administration of Trappsol® Cyclo
TM
to study subjects, it was detected in subjects' cerebrospinal fluid. The clinical significance of these findings will be determined as part of the final analysis of both clinical trials.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CTD Holdings, Inc.
Date:
February 6, 2018
By:
/s/
Jeffrey L. Tate
Jeffrey L. Tate
Chief
Operating Officer